Establishment Labs (ESTA)
(Delayed Data from NSDQ)
$42.33 USD
-1.23 (-2.82%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $42.27 -0.06 (-0.14%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Establishment Labs Holdings Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 40 | 66 | 53 | 85 | 38 |
Receivables | 47 | 35 | 24 | 19 | 23 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 79 | 37 | 28 | 23 | 29 |
Other Current Assets | 8 | 12 | 7 | 5 | 7 |
Total Current Assets | 175 | 150 | 113 | 132 | 96 |
Net Property & Equipment | 77 | 51 | 19 | 16 | 16 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 8 | 5 | 5 | 5 | 4 |
Deposits & Other Assets | 5 | 1 | 1 | 1 | 0 |
Total Assets | 269 | 211 | 140 | 156 | 117 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 42 | 20 | 14 | 10 | 10 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 14 | 17 | 16 | 15 | 11 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2 | 2 | 1 | 2 | 2 |
Total Current Liabilities | 57 | 39 | 32 | 26 | 23 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 189 | 175 | 52 | 50 | 48 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 2 | 3 | 4 | 6 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 250 | 219 | 89 | 81 | 77 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 316 | 224 | 220 | 213 | 148 |
Capital Surplus | 64 | 50 | 37 | 27 | 21 |
Retained Earnings | -360 | -282 | -206 | -165 | -127 |
Other Equity | 2 | 3 | 4 | 3 | 1 |
Treasury Stock | 3 | 3 | 3 | 3 | 3 |
Total Shareholder's Equity | 18 | -8 | 51 | 75 | 40 |
Total Liabilities & Shareholder's Equity | 269 | 211 | 140 | 156 | 117 |
Total Common Equity | 18 | -8 | 51 | 75 | 40 |
Shares Outstanding | 25.80 | 24.30 | 24.00 | 23.40 | 20.60 |
Book Value Per Share | 0.71 | -0.34 | 2.11 | 3.20 | 1.92 |
Fiscal Year End for Establishment Labs Holdings Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 55 | 73 | 40 | 52 | 90 |
Receivables | 60 | 51 | 47 | 55 | 51 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 64 | 72 | 79 | 68 | 56 |
Other Current Assets | 7 | 7 | 8 | 12 | 11 |
Total Current Assets | 186 | 204 | 175 | 187 | 209 |
Net Property & Equipment | 80 | 79 | 77 | 73 | 66 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 11 | 10 | 8 | 6 | 5 |
Deposits & Other Assets | 5 | 5 | 5 | 1 | 2 |
Total Assets | 285 | 302 | 269 | 271 | 285 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 28 | 31 | 42 | 29 | 24 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 12 | 15 | 14 | 19 | 17 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2 | 2 | 2 | 2 | 1 |
Total Current Liabilities | 42 | 48 | 57 | 50 | 43 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 194 | 192 | 189 | 185 | 182 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 2 | 2 | 2 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 240 | 245 | 250 | 240 | 230 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 368 | 367 | 316 | 311 | 310 |
Capital Surplus | 70 | 67 | 64 | 60 | 56 |
Retained Earnings | -393 | -376 | -360 | -340 | -310 |
Other Equity | 3 | 2 | 2 | 2 | 2 |
Treasury Stock | 3 | 3 | 3 | 3 | 3 |
Total Shareholder's Equity | 45 | 57 | 18 | 30 | 55 |
Total Liabilities & Shareholder's Equity | 285 | 302 | 269 | 271 | 285 |
Total Common Equity | 45 | 57 | 18 | 30 | 55 |
Shares Outstanding | 27.50 | 27.40 | 25.80 | 25.70 | 25.70 |
Book Value Per Share | 1.64 | 2.08 | 0.71 | 1.19 | 2.14 |